Cite Filings / INM / 0001213900-26-080417

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

InMed Pharmaceuticals Inc. Filed 2026-07-22 Acc 0001213900-26-080417

Documents 1

425 Prospectus/Communication re Business Combination , ea0298644-8k425_inmed.htm

Around this filing

2026-07-22 425 Prospectus/Communication re Business Combination
2026-07-22 425 Prospectus/Communication re Business Combination
2026-07-22 8-K Regulation FD disclosure · Other events
2026-07-20 425 Prospectus/Communication re Business Combination
2026-07-17 4 10% owner bought 1,000 shares at $1.56 ($1,555)
2026-07-16 4 10% owner bought 20,546 shares at $1.55 ($31,846)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ea0298644-8k425_inmed.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…